Eli Lilly’s 340B deadline passes: What hospitals should know
(By: Ella Jeffries for Becker’s Hospital Review ) Eli Lilly’s deadline for hospitals to submit claims data or lose 340B
Read More(By: Ella Jeffries for Becker’s Hospital Review ) Eli Lilly’s deadline for hospitals to submit claims data or lose 340B
Read More(By: Alan Condon for Becker’s Hospital Review ) Three health systems have filed federal lawsuits against CVS Health, alleging the
Read More(By: Ella Jeffries for Becker’s Hospital Review) Eli Lilly and Co. will require all 340B covered entities to submit claims-level
Read More(By: Alan Condon for Becker’s Hospital Review ) The American Hospital Association, Maine Hospital Association and four safety-net hospitals have
Read More(By: Madeline Ashley, Erica Cerutti, Alan Condon, and Jakob Emerson for Becker’s Hospital Review ) Congress is staring down a
Read More(By: Alexandra Murphy for Becker’s Hospital Review ) A group of House lawmakers is urging HHS to scrap or revise
Read More(By: Alexandra Murphy for Becker’s Hospital Review ) More than three decades ago, Congress created the 340B program to help
Read More(By: Alexandra Murphy for Becker’s Hospital Review ) As federal scrutiny and legislative proposals continue around the 340B drug pricing
Read More(By Alexandra Murphy for Becker’s Hospital Review ) The Health Resources and Services Administration has issued a warning to Sanofi
Read More(By Alexandra Murphy for Becker’s Hospital Review ) A total of $66.3 billion in outpatient drugs was purchased through the
Read More